- © 2012 Marshfield Clinic
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Probably Induced by Cefotaxime: a Report of Two Cases
- Karim Aouam, MD*⇓,
- Amel Chaabane, MD*,
- Adnen Toumi, MD†,
- Nadia Ben Fredj, MD*,
- Foued Ben Romdhane, MD†,
- Naceur A Boughattas, PhD* and
- Mohamed Chakroun, MD†
- *Pharmacology Department, University Hospital, Monastir, Tunisia
- †Infectious Disease Department, University Hospital, Monastir, Tunisia
- Corresponding Author: Karim Aouam, MD, Laboratoire de Pharmacologie, Faculté de Médecine de Monastir, Rue Avicenne, 5019 Monastir, Tunisia, Tel: 216-98-67.62.24, Fax: 216-73-46.07.37, Email: aouam_k{at}yahoo.fr
Abstract
We report two cases, one of a 52-year-old man and one of a 32-year-old man, who were treated with cefotaxime. On day 23 and day 28 of the treatment, respectively, the patients manifested clinically with fever, pruriginous skin rash, and facial edema. Blood tests showed marked eosinophilia and atypical lymphocytosis for both patients, and hepatic cytolysis only in the second patient. Cefotaxime was discontinued in both patients; the clinico-biological picture improved gradually and completely disappeared approximately 4 weeks later. Six weeks after complete recovery, both patients underwent intradermal testing which was positive to cefotaxime (2 mg/ml) at the 48-hour reading and negative to benzylpenicillin, amoxicillin, and cefazolin at the 20-minute and 48-hour readings. These clinical pictures suggest drug rash with eosinophilia and systemic symptoms (DRESS) induced by cefotaxime. To the best of our knowledge, only one case of cefotaxime-induced DRESS has been reported in the medical literature. Thus, we add two new cases of cefotaxime-induced DRESS and emphasize the usefulness and safety of intradermal testing in establishing the diagnosis.
